Full-length L1CAM and not its δ2δ27 splice variant promotes metastasis through induction of gelatinase expression

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Hauser, Stephanie ^a   Bickel, Laura ^a   Weinspach, Dirk ^a   Gerg, Michael ^a   Schäfer, Michael K ^b   Pfeifer, Marco ^c   Hazin, John ^c   Schelter, Florian ^a   Weidle, Ulrich H ^d   Ramser, Juliane ^a   Volkmann, Juliane ^a   Meindl, Alfons ^a   Schmitt, Manfred ^a   Schrötzlmair, Florian ^a   Altevogt, Peter ^c   Krüger, Achim ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Abteilung D015 für Translationale Immunologie des Deutschen Krebsforschungszentrums   (Germany)

^d ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GELATINASE A; GELATINASE B; L1 CELL ADHESION MOLECULE; UNCLASSIFIED DRUG; NERVE CELL ADHESION MOLECULE L1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER METASTASIS; LUNG METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA SPLICING; UPREGULATION; ALTERNATIVE RNA SPLICING; ANIMAL; BIOSYNTHESIS; COLORECTAL TUMOR; DISEASE COURSE; ENDOSOME; ENZYME INDUCTION; ENZYMOLOGY; FEMALE; FIBROSARCOMA; GENETICS; METABOLISM; METASTASIS; NEOPLASM; OVARY TUMOR; PATHOLOGY; PROTEIN TRANSPORT; T CELL LYMPHOMA; TUMOR CELL LINE;

MUS;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; ENDOSOMES; ENZYME INDUCTION; FEMALE; FIBROSARCOMA; HUMANS; LYMPHOMA, T-CELL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM METASTASIS; NEOPLASMS; NEURAL CELL ADHESION MOLECULE L1; OVARIAN NEOPLASMS; PROTEIN TRANSPORT;

EID: 79955551591     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018989     Document Type: Article

References (73)

1. Moos M, Tacke R, Scherer H, Teplow D, Fruh K, et al. (1988) Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334: 701-703.
2. Reid RA, Hemperly JJ, (1992) Variants of human L1 cell adhesion molecule arise through alternate splicing of RNA. J Mol Neurosci 3: 127-135.
3. Breitbart RE, Andreadis A, Nadal-Ginard B, (1987) Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu Rev Biochem 56: 467-495.
4. Ghigna C, Valacca C, Biamonti G, (2008) Alternative splicing and tumor progression. Curr Genomics 9: 556-570.
5. Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, et al. (2007) Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 8: 349-357.
6. Skotheim RI, Nees M, (2007) Alternative splicing in cancer: noise, functional, or systematic? Int J Biochem Cell Biol 39: 1432-1449.
7. Srebrow A, Kornblihtt AR, (2006) The connection between splicing and cancer. J Cell Sci 119: 2635-2641.
8. Scotlandi K, Zuntini M, Manara MC, Sciandra M, Rocchi A, et al. (2007) CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity. Oncogene 26: 6604-6618.
9. Coutelle O, Nyakatura G, Taudien S, Elgar G, Brenner S, et al. (1998) The neural cell adhesion molecule L1: genomic organisation and differential splicing is conserved between man and the pufferfish Fugu. Gene 208: 7-15.
10. Jacob J, Haspel J, Kane-Goldsmith N, Grumet M, (2002) L1 mediated homophilic binding and neurite outgrowth are modulated by alternative splicing of exon 2. J Neurobiol 51: 177-189.
11. De Angelis E, Brummendorf T, Cheng L, Lemmon V, Kenwrick S, (2001) Alternative use of a mini exon of the L1 gene affects L1 binding to neural ligands. J Biol Chem 276: 32738-32742.
12. Gouveia RM, Gomes CM, Sousa M, Alves PM, Costa J, (2008) Kinetic analysis of L1 homophilic interaction: role of the first four immunoglobulin domains and implications on binding mechanism. J Biol Chem 283: 28038-28047.
13. Kamiguchi H, Long KE, Pendergast M, Schaefer AW, Rapoport I, et al. (1998) The neural cell adhesion molecule L1 interacts with the AP-2 adaptor and is endocytosed via the clathrin-mediated pathway. J Neurosci 18: 5311-5321.
14. Schaefer AW, Kamiguchi H, Wong EV, Beach CM, Landreth G, et al. (1999) Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J Biol Chem 274: 37965-37973.
15. Schaefer AW, Kamei Y, Kamiguchi H, Wong EV, Rapoport I, et al. (2002) L1 endocytosis is controlled by a phosphorylation-dephosphorylation cycle stimulated by outside-in signaling by L1. J Cell Biol 157: 1223-1232.
16. Siesser PF, Maness PF, (2009) L1 cell adhesion molecules as regulators of tumor cell invasiveness. Cell Adh Migr 3: 275-277.
17. Schafer MK, Altevogt P, (2010) L1CAM malfunction in the nervous system and human carcinomas. Cell Mol Life Sci 67: 2425-2437.
18. Gavert N, Ben-Shmuel A, Raveh S, Ben-Ze'ev A, (2008) L1-CAM in cancerous tissues. Expert Opin Biol Ther 8: 1749-1757.
19. Schroder C, Schumacher U, Fogel M, Feuerhake F, Muller V, et al. (2009) Expression and prognostic value of L1-CAM in breast cancer. Oncol Rep 22: 1109-1117.
20. Kaifi JT, Reichelt U, Quaas A, Schurr PG, Wachowiak R, et al. (2007) L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol 20: 1183-1190.
21. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, et al. (2003) L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362: 869-875.
22. Boo YJ, Park JM, Kim J, Chae YS, Min BW, et al. (2007) L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Ann Surg Oncol 14: 1703-1711.
23. Wolterink S, Moldenhauer G, Fogel M, Kiefel H, Pfeifer M, et al. (2010) Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma. Cancer Res 70: 2504-2515.
24. Novak-Hofer I, Cohrs S, Grunberg J, Friedli A, Schlatter MC, et al. (2008) Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells. Cancer Lett 261: 193-204.
25. Arlt MJ, Novak-Hofer I, Gast D, Gschwend V, Moldenhauer G, et al. (2006) Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 66: 936-943.
26. Miura M, Asou H, Kobayashi M, Uyemura K, (1992) Functional expression of a full-length cDNA coding for rat neural cell adhesion molecule L1 mediates homophilic intercellular adhesion and migration of cerebellar neurons. J Biol Chem 267: 10752-10758.
27. Itoh K, Sakurai Y, Asou H, Umeda M, (2000) Differential expression of alternatively spliced neural cell adhesion molecule L1 isoforms during oligodendrocyte maturation. J Neurosci Res 60: 579-586.
28. Takeda Y, Asou H, Murakami Y, Miura M, Kobayashi M, et al. (1996) A nonneuronal isoform of cell adhesion molecule L1: tissue-specific expression and functional analysis. J Neurochem 66: 2338-2349.
29. Euer NI, Kaul S, Deissler H, Mobus VJ, Zeillinger R, et al. (2005) Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens. Oncol Rep 13: 375-387.
30. Lesko E, Majka M, (2008) The biological role of HGF-MET axis in tumor growth and development of metastasis. Front Biosci 13: 1271-1280.
31. Jakowlew SB, (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25: 435-457.
32. Cairns RA, Khokha R, Hill RP, (2003) Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 3: 659-671.
33. Gast D, Riedle S, Kiefel H, Muerkoster SS, Schafer H, et al. (2008) The RGD integrin binding site in human L1-CAM is important for nuclear signaling. Exp Cell Res 314: 2411-2418.
34. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, et al. (1994) Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis 12: 296-304.
35. Young TN, Rodriguez GC, Rinehart AR, Bast RC Jr, Pizzo SV, et al. (1996) Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2. Gynecol Oncol 62: 89-99.
36. Davies B, Waxman J, Wasan H, Abel P, Williams G, et al. (1993) Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369.
37. Zhang L, Shi J, Feng J, Klocker H, Lee C, et al. (2004) Type IV collagenase (matrix metalloproteinase-2 and-9) in prostate cancer. Prostate Cancer Prostatic Dis 7: 327-332.
38. Togawa D, Koshino T, Saito T, Takagi T, Machida J, (1999) Highly activated matrix metalloproteinase-2 secreted from clones of metastatic lung nodules of nude mice injected with human fibrosarcoma HT1080. Cancer Lett 146: 25-33.
39. Gerg M, Kopitz C, Schaten S, Tschukes A, Kahlert C, et al. (2008) Distinct Functionality of Tumor Cell-Derived Gelatinases during Formation of Liver Metastases. Mol Cancer Res 6: 341-351.
40. Yu Q, Stamenkovic I, (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176.
41. Kim HJ, Taylor LJ, Bar-Sagi D, (2007) Spatial regulation of EGFR signaling by Sprouty2. Curr Biol 17: 455-461.
42. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, et al. (2006) The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim Biophys Acta 1766: 120-139.
43. Shtutman M, Levina E, Ohouo P, Baig M, Roninson IB, (2006) Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res 66: 11370-11380.
44. Raveh S, Gavert N, Ben-Ze'ev A, (2009) L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett 282: 137-145.
45. Geismann C, Morscheck M, Koch D, Bergmann F, Ungefroren H, et al. (2009) Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res 69: 4517-4526.
46. Huszar M, Pfeifer M, Schirmer U, Kiefel H, Konecny GE, et al. (2010) Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J Pathol 220: 551-561.
47. Tazi J, Bakkour N, Stamm S, (2009) Alternative splicing and disease. Biochim Biophys Acta 1792: 14-26.
48. Gast D, Riedle S, Schabath H, Schlich S, Schneider A, et al. (2005) L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int J Cancer 115: 658-665.
49. Gast D, Riedle S, Issa Y, Pfeifer M, Beckhove P, et al. (2008) The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene 27: 1281-1289.
50. Geiger TR, Peeper DS, (2009) Metastasis mechanisms. Biochim Biophys Acta 1796: 293-308.
51. Bjorklund M, Koivunen E, (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755: 37-69.
52. Urech L, Bittermann AG, Hubbell JA, Hall H, (2005) Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. Biomaterials 26: 1369-1379.
53. Schmid RS, Maness PF, (2008) L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol 18: 245-250.
54. Gavert N, Ben-Shmuel A, Lemmon V, Brabletz T, Ben-Ze'ev A, (2010) Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci 123: 2135-2143.
55. Tyukhtenko S, Deshmukh L, Kumar V, Lary J, Cole J, et al. (2008) Characterization of the neuron-specific L1-CAM cytoplasmic tail: naturally disordered in solution it exercises different binding modes for different adaptor proteins. Biochemistry 47: 4160-4168.
56. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, et al. (2004) Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 279: 28880-28888.
57. Islam R, Kristiansen LV, Romani S, Garcia-Alonso L, Hortsch M, (2004) Activation of EGF receptor kinase by L1-mediated homophilic cell interactions. Mol Biol Cell 15: 2003-2012.
58. Murphy JE, Padilla BE, Hasdemir B, Cottrell GS, Bunnett NW, (2009) Endosomes: a legitimate platform for the signaling train. Proc Natl Acad Sci U S A 106: 17615-17622.
59. Shepherd JH, (1989) Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 96: 889-892.
60. Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE, (1981) Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res 41: 1751-1756.
61. Kopitz C, Anton M, Gansbacher B, Krüger A, (2005) Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host. Cancer Res 65: 8608-8612.
62. Krüger A, Schirrmacher V, von Hoegen P, (1994) Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58: 275-284.
63. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, et al. (1995) A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23: 628-633.
64. Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, et al. (1994) A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A 91: 9564-9568.
65. Arlt M, Kopitz C, Pennington C, Watson KL, Krell HW, et al. (2002) Increase in Gelatinase-specificity of Matrix Metalloproteinase Inhibitors Correlates with Antimetastatic Efficacy in a T-Cell Lymphoma Model. Cancer Res 62: 5543-5550.
66. Jouet M, Rosenthal A, Kenwrick S, (1995) Exon 2 of the gene for neural cell adhesion molecule L1 is alternatively spliced in B cells. Brain Res Mol Brain Res 30: 378-380.
67. Mechtersheimer S, Gutwein P, Agmon-Levin N, Stoeck A, Oleszewski M, et al. (2001) Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 155: 661-673.
68. Krüger A, Arlt MJ, Gerg M, Kopitz C, Bernardo MM, et al. (2005) Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res 65: 3523-3526.
69. Falcon-Perez JM, Nazarian R, Sabatti C, Dell'Angelica EC, (2005) Distribution and dynamics of Lamp1-containing endocytic organelles in fibroblasts deficient in BLOC-3. J Cell Sci 118: 5243-5255.
70. Hoepfner S, Severin F, Cabezas A, Habermann B, Runge A, et al. (2005) Modulation of receptor recycling and degradation by the endosomal kinesin KIF16B. Cell 121: 437-450.
71. Ghosh RN, Mallet WG, Soe TT, McGraw TE, Maxfield FR, (1998) An endocytosed TGN38 chimeric protein is delivered to the TGN after trafficking through the endocytic recycling compartment in CHO cells. J Cell Biol 142: 923-936.
72. Keller P, Toomre D, Diaz E, White J, Simons K, (2001) Multicolour imaging of post-Golgi sorting and trafficking in live cells. Nat Cell Biol 3: 140-149.
73. Schäfer MK, Nam YC, Moumen A, Keglowich L, Bouche E, et al. (2010) L1 syndrome mutations impair neuronal L1 function at different levels by divergent mechanisms. Neurobiol Dis 40: 222-237.